Sign in to continue:

Thursday, April 30th, 2026

mDR Limited Extraordinary General Meeting 2026: Rights Cum Warrants Issue, Whitewash Resolution, and Shareholder Q&A Highlights





mDR Limited EGM Detailed Report: Rights cum Warrants Issue and Strategic Insights

mDR Limited Approves S\$130 Million Rights cum Warrants Issue at EGM: Key Highlights, Strategic Rationale, and Shareholder Impact

Summary of Extraordinary General Meeting (EGM) Held on 31 March 2026

mDR Limited convened its highly anticipated Extraordinary General Meeting (EGM) on 31 March 2026, where shareholders overwhelmingly approved two critical resolutions that are set to shape the Group’s financial trajectory and growth strategy. The meeting was chaired by Executive Chairman Mr. Edward Lee Ewe Ming and attended by key board members, management, auditors, and shareholders.

Key Resolutions Passed

1. Rights cum Warrants Issue

  • Resolution Details: Shareholders approved a renounceable non-underwritten Rights cum Warrants Issue, comprising up to 1,450,183,780 new ordinary shares at an issue price of S\$0.045 per share, with up to 1,450,183,780 free detachable warrants. Each warrant entitles holders to subscribe for one new share at an exercise price of S\$0.045, exercisable within five years from issuance.
  • Provisional Allotment: Five (5) Rights Shares for every three (3) existing shares held, and one (1) Warrant for every one (1) Rights Share subscribed.
  • Poll Results: The resolution passed with a landslide majority: 99.65% votes FOR, only 0.35% AGAINST, representing 626,085,003 shares.
  • Potential Proceeds: The maximum funds to be raised are S\$65 million from the Rights and an additional S\$65.3 million from the exercise of Warrants, totaling over S\$130 million.

2. Whitewash Resolution

  • Purpose: Shareholders (excluding the LZ Group and their concert parties) irrevocably waived their rights to receive a mandatory general offer from the LZ Group resulting from increased shareholding through this exercise.
  • Poll Results: Passed with 99.07% votes FOR, 0.93% AGAINST (235,570,859 shares represented).

Strategic Rationale and Use of Proceeds

  • The strengthened balance sheet is intended to provide financial flexibility, enabling the Group to seize growth opportunities, invest in new businesses, and repay debt as appropriate.
  • General corporate purposes, including but not limited to portfolio investments and potential acquisitions, are the primary use of proceeds. No specific acquisitions have been identified at this time, but the Board emphasized the proceeds will mainly go toward spreading capital across multiple companies within the Investment business.
  • The structure of this funding exercise is designed to maximize capital raised at the highest possible price with the lowest discount to existing market price, balancing the need to encourage maximum shareholder participation with the desire to minimize dilution.
  • Importantly, about S\$29.9 million of the proceeds will be used to set off existing shareholder loans (pre-funded by the Chairman), and up to S\$35 million will be fresh cash, depending on public subscription levels. The Chairman gave a strong indication of support, committing to subscribe for his entitlement and up to 500 million excess Rights shares.

Shareholder Considerations and Potential Price Sensitivities

  • Potential for Price Movement: The approval of such a significant capital raise could be price sensitive, especially given that the theoretical ex-rights price is only a small discount to the current trading price. This could affect market perception and share price in the short term.
  • Dilution and Value Transfer: The Board highlighted that dilution is offset by the increased capital and that shareholders unable to participate can monetize their rights by trading them. The structure allows minority shareholders to “right-size” their participation without economic disadvantage, provided they take action.
  • Allocation of Excess Rights: The allocation of excess Rights Shares with Warrants will favor rounding of odd lots and will prioritize ordinary shareholders over Directors and Substantial Shareholders. The company also committed to avoid any transfer of controlling interest unless approved by shareholders.
  • Financial Position: Despite a reported net loss for FY2025, the Group’s Net Tangible Assets (NTA) have increased, reflecting unrealized gains and positive comprehensive income, not just profit and loss figures. The Group maintains conservative gearing and has ample liquidity via its investment portfolio.
  • Investment Strategy and Lessons Learned: The Board acknowledged past losses in the investment portfolio, particularly in Chinese distressed bonds, but emphasized recent gains have more than offset these losses. The investment approach remains contrarian but is balanced with strong risk management and oversight by an internal investment committee and an external CMS-licensed advisor.
  • Transparency: The company will increase transparency by providing weekly NTA updates and disclosing top investment portfolio holdings in its annual report.

Historical Performance and Outlook

  • Total Shareholder Return (TSR) has been negative for the past 5, 8, and 12 years, with a 5-year TSR of -0.40%, 8-year TSR of -58.08%, and 12-year TSR of -78.56%. The current management has been in place since 2017, during which time shareholder equity increased from S\$64.3 million to S\$139.1 million, and S\$18.95 million has been returned to shareholders via dividends and buybacks.
  • The company last undertook a similar fund-raising exercise in 2018, underscoring the current move’s significance.
  • The Board remains optimistic about future growth, citing recent positive contributions from the Investment segment and ongoing transformation efforts.

Q&A Highlights of Investor Concerns

  • Bonus Warrants: No plans for bonus warrants issuance; the economic value has not changed despite fewer warrants due to longer (5-year) tenure.
  • Profitability: While profit growth is expected due to scale, shareholders are reminded that the rights issue size is small relative to the overall portfolio. Upcoming annual reports will increase transparency on investment holdings.
  • Current Liabilities: The Group’s current liabilities are primarily due to share financing and are short-term rollovers for interest rate efficiency. The company maintains strong liquidity and a conservative gearing profile.
  • Strategic Priorities: Business growth and stability remain core, with ongoing investments in the omni-channel distribution business, expansion of the MVNO segment (ZYM Mobile), cost optimization in After Market Solutions, and a diversified, long-term view for the Investment segment.

Conclusion

The successful passage of the Rights cum Warrants Issue and Whitewash Resolution marks a pivotal step for mDR Limited, providing the company with substantial capital to pursue growth opportunities, strengthen its balance sheet, and enhance shareholder value. The strong support from the Chairman and controlling shareholders, combined with transparent governance and strategic clarity, position mDR for future growth, although past TSR performance and market conditions should be carefully considered by investors.


Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. The views expressed are based on information from the mDR Limited EGM minutes and related shareholder communications. Investors should conduct their own analysis and consult professional advisers before making investment decisions. Past performance is not indicative of future results. mDR Limited and its management undertake no obligation to update forward-looking statements except as required by law.




View MDR Limited Historical chart here



   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today